Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)

China flag China · Delayed Price · Currency is CNY
4.790
+0.030 (0.63%)
Jul 3, 2026, 3:00 PM CST
Market Cap4.50B -57.4%
Revenue (ttm)509.95M -75.2%
Net Income-1.62B
EPS-1.73
Shares Out 939.12M
PE Ration/a
Forward PEn/a
Dividend0.15 (3.15%)
Ex-Dividend DateAug 20, 2025
Volume36,361,639
Open4.800
Previous Close4.760
Day's Range4.670 - 4.980
52-Week Range4.210 - 13.480
Beta0.24
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHA:603567

Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields. The company was founded in 1996 and is based in Hulin, China. [Read more]

Sector Healthcare
Founded 1996
Employees 1,961
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603567
Full Company Profile

Financial Performance

Financial Statements